Skip to content

Ketorolac as an additive to bupivacaine in pectoral nerve block

Ketorolac as an adjuvant to bupivacaine in ultrasound guided pectoral nerve block (I+II) for patients undergoing modified radical mastectomy under general anaesthesia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR201907766143535
Enrollment
46
Registered
2019-07-05
Start date
2019-06-25
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

ketorolac as an additive to bupivacaine in pectoral nerve block
pecs block by bupivacaine only

Sponsors

Suez Canal University hospitals
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: • Females aged between 21 – 60 years • Patients ASA class II (American Society of Anesthesiologists physical status Grade II) = (patients with mild systemic disease and no functional limitations). • Patients with Body Mass Index (BMI) = 35.

Exclusion criteria

Exclusion criteria: • Patients with history of bleeding diathesis or on anticoagulant. • Patients with relevant drug allergy. • Prior surgery in the supraclavicular, infraclavicularor axillary regions. • Patients with psychiatric illnesses, opioid dependence; alcohol or drug abuse that would interfere with perception and assessment of pain. • Patients with any metastasis. • Deformities of (face, teeth,tongue,palate,mandible,neck) that interfere with airway management.

Design outcomes

Primary

MeasureTime frame
the first time of analgesic requirement in both groups.;postoperative total dose of analgesic consumption;postoperative hemodynamics and visual analogue score

Secondary

MeasureTime frame
intra-operative hemodynamics;intraoperative analgesic consumption

Countries

Egypt

Contacts

Public ContactAhmed El liilly

lecturer of anaesthesia

ahmed.lilly@gmail.com+201129111066

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026